M. Kulyk & Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-460
| Closed | -$239K | – | 108 |
|
|
2024
Q4 | $239K | Buy |
460
+6
| +1% | +$3.12K | 0.05% | 92 |
|
|
2024
Q3 | $281K | Sell |
454
-24
| -5% | -$14.8K | 0.06% | 94 |
|
|
2024
Q2 | $264K | Sell |
478
-48
| -9% | -$26.5K | 0.06% | 92 |
|
|
2024
Q1 | $306K | Buy |
526
+3
| +0.6% | +$1.74K | 0.07% | 85 |
|
|
2023
Q4 | $278K | Hold |
523
| – | – | 0.06% | 87 |
|
|
2023
Q3 | $265K | Sell |
523
-53
| -9% | -$26.8K | 0.07% | 82 |
|
|
2023
Q2 | $301K | Buy |
576
+17
| +3% | +$8.87K | 0.08% | 86 |
|
|
2023
Q1 | $322K | Buy |
559
+18
| +3% | +$10.4K | 0.1% | 85 |
|
|
2022
Q4 | $298K | Hold |
541
| – | – | 0.1% | 81 |
|
|
2022
Q3 | $274K | Buy |
541
+24
| +5% | +$12.2K | 0.1% | 84 |
|
|
2022
Q2 | $281K | Sell |
517
-91
| -15% | -$49.5K | 0.09% | 82 |
|
|
2022
Q1 | $359K | Buy |
608
+78
| +15% | +$46.1K | 0.1% | 80 |
|
|
2021
Q4 | $354K | Hold |
530
| – | – | 0.09% | 68 |
|
|
2021
Q3 | $303K | Hold |
530
| – | – | 0.1% | 60 |
|
|
2021
Q2 | $267K | Hold |
530
| – | – | 0.1% | 58 |
|
|
2021
Q1 | $242K | Buy |
+530
| New | +$242K | 0.09% | 65 |
|